首页> 外文期刊>Seminars in oncology nursing >Complete Decongestive Therapy for Treatment of Lymphedema
【24h】

Complete Decongestive Therapy for Treatment of Lymphedema

机译:完整的半充血性疗法治疗淋巴水肿

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: To summarize current evidence on the management of lymphedema and to provide management recommendations. Data Sources: Eleven databases, including PubMed and CINAHL from 2004-2011. Conclusion: Complete decongestive therapy (CDT) is effective in reducing lymphedema, although the contribution of each individual complete decongestive therapy component has not been determined. In general, levels of evidence for complete decongestive therapy are mid-level. Implications for Nursing Practice: Oncology nurses and health care providers play key roles in assessing needs and prescribing interventions to support patients with lymphedema from admission to discharge. Reviewing risk-reduction strategies and supporting the patient with lymphedema to continue self-care when undergoing medical treatment empowers patients to be proactive in health maintenance. Identifying potential problems and making appropriate referral to a lymphedema specialist avoids triggering or worsening lymphedema.
机译:目的:总结有关淋巴水肿治疗的最新证据并提供治疗建议。数据来源:2004-2011年的11个数据库,包括PubMed和CINAHL。结论:完全去充血疗法(CDT)可以有效减少淋巴水肿,尽管尚未确定每个单独的完全去充血疗法成分的作用。通常,完全性充血治疗的证据水平为中等水平。对护理实践的意义:肿瘤护士和医疗保健提供者在评估需求和制定干预措施以支持淋巴水肿患者从入院到出院之间起着关键作用。审查降低风险的策略并在接受药物治疗时支持患有淋巴水肿的患者继续自我护理,使患者能够积极主动地进行健康维护。确定潜在问题并适当地推荐给淋巴水肿专家,可以避免触发或加重淋巴水肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号